Apellis Stock Price History Breakdown

APLS
 Stock
  

USD 47.52  0.64  1.37%   

As of today, the current price of Apellis Pharmaceuticals is  47.52 , as last reported on the 8th of December, with the highest price reaching  48.12  and the lowest price hitting  46.57  during the day.
Apellis Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had -0.11% of return per unit of standard deviation over the last 3 months. Macroaxis philosophy in foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Apellis Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Apellis Pharmaceuticals risk adjusted performance of (0.06), and Mean Deviation of 2.93 to double-check the risk estimate we provide.
  
As of 12/08/2022, Net Income Common Stock is likely to drop to about (766 M). As of 12/08/2022, Price to Book Value is likely to grow to 23.79, while Price to Earnings Ratio are likely to drop (5.77) . Apellis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Most Recent Activity

Shares Float
84 M
Net Income Applicable To Common Shares
-746.4 M
Shares Outstanding
110.6 M
Shares Short Prior Month
9.7 M
Earnings Share
(7.87) 
Shares Short
10.4 M

Apellis Pharmaceuticals December 8, 2022 Stock Price Synopsis

Apellis Pharmaceuticals Price Action Indicator 0.50 
Apellis Pharmaceuticals Accumulation Distribution 20,825 
Apellis Pharmaceuticals Price Daily Balance Of Power 0.41 
Apellis Pharmaceuticals Price Rate Of Daily Change 1.01 

Apellis Pharmaceuticals December 8, 2022 Stock Price Analysis

Share Download
When benchmark price declines in a down market, there may be an uptick in Apellis Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Apellis Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Apellis Stock and then apply it to test your longer-term investment strategies against Apellis.

Apellis Pharmaceuticals Stock Price History Chart

There are several ways to analyze Apellis Stock price data. The simplest method is using a basic Apellis candlestick price chart, which shows Apellis Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

90 Days Highest PriceSeptember 30, 202268.3
90 Days Lowest PriceNovember 17, 202243.24

Apellis Stock Price History Data

The price series of Apellis Pharmaceuticals for the period between Fri, Sep 9, 2022 and Thu, Dec 8, 2022 has a statistical range of 25.29 with a coefficient of variation of 12.38. The prices are distributed with arithmetic mean of 56.51. The median price for the last 90 days is 58.4.
OpenHighLowCloseVolume
12/07/2022 46.58  48.12  46.57  47.52  646,517 
12/06/2022 49.32  49.47  46.81  46.88  1,140,501 
12/05/2022 50.38  50.50  48.41  49.38  990,498 
12/02/2022 50.13  51.70  49.26  50.63  877,544 
12/01/2022 49.93  50.92  48.36  49.79  922,308 
11/30/2022 51.07  51.86  47.62  49.93  1,399,654 
11/29/2022 50.22  51.26  49.81  50.12  1,012,632 
11/28/2022 51.03  51.90  49.16  50.64  1,352,902 
11/25/2022 48.87  51.18  48.87  50.96  555,881 
11/23/2022 49.61  50.21  48.61  49.49  888,074 
11/22/2022 48.08  49.38  46.14  48.98  1,024,588 
11/21/2022 50.09  51.48  47.96  48.23  1,287,817 
11/18/2022 48.23  52.61  48.14  50.45  5,224,122 
11/17/2022 43.50  43.98  42.15  43.24  1,791,450 
11/16/2022 46.57  46.84  43.46  43.77  1,517,343 
11/15/2022 48.01  49.34  45.77  46.61  1,069,709 
11/14/2022 45.28  47.17  44.75  46.88  1,646,287 
11/11/2022 45.50  46.46  44.16  45.15  1,121,324 
11/10/2022 43.53  45.25  42.67  45.09  3,013,605 
11/09/2022 46.82  48.22  43.75  43.99  1,988,089 
11/08/2022 46.47  49.22  45.12  47.11  2,743,240 
11/07/2022 50.84  50.96  46.33  47.62  3,527,331 
11/04/2022 49.99  54.00  45.24  50.42  7,914,720 
11/03/2022 58.56  61.10  57.63  60.05  821,778 
11/02/2022 60.62  62.24  59.10  59.25  769,636 
11/01/2022 60.83  61.99  58.64  60.66  680,355 
10/31/2022 60.17  61.25  59.35  60.49  820,188 
10/28/2022 59.32  60.83  58.57  60.60  807,567 
10/27/2022 59.08  60.41  57.92  59.24  697,947 
10/26/2022 60.04  60.94  57.34  58.41  744,057 
10/25/2022 59.09  61.33  59.09  59.82  678,400 
10/24/2022 60.24  60.24  56.51  58.45  848,472 
10/21/2022 58.06  60.02  57.31  59.82  837,746 
10/20/2022 58.23  59.99  57.11  58.00  1,001,242 
10/19/2022 58.24  58.50  56.46  57.09  943,600 
10/18/2022 59.91  61.83  58.68  59.00  1,356,000 
10/17/2022 58.23  59.99  57.11  58.40  1,001,242 
10/14/2022 59.31  59.90  56.15  56.94  861,917 
10/13/2022 57.07  58.90  54.74  58.72  934,315 
10/12/2022 58.03  58.03  54.79  57.69  843,339 
10/11/2022 58.45  59.01  54.73  57.46  1,256,271 
10/10/2022 57.50  58.36  55.88  57.91  619,048 
10/07/2022 58.81  59.70  57.89  58.23  965,222 
10/06/2022 57.19  60.00  56.81  59.10  1,481,117 
10/05/2022 59.18  59.54  57.23  57.69  1,940,050 
10/04/2022 61.82  63.22  59.66  60.49  2,451,103 
10/03/2022 66.66  66.80  58.46  61.04  4,856,698 
09/30/2022 64.99  69.89  64.99  68.30  2,101,584 
09/29/2022 62.37  68.13  59.96  65.41  2,194,712 
09/28/2022 62.49  63.71  61.43  63.00  801,061 
09/27/2022 60.06  62.81  60.00  61.76  980,855 
09/26/2022 58.25  62.41  58.16  59.30  830,088 
09/23/2022 60.78  61.17  56.02  58.32  1,688,618 
09/22/2022 61.96  62.29  59.78  61.09  866,414 
09/21/2022 64.16  64.97  62.65  62.90  939,273 
09/20/2022 63.40  64.80  62.28  63.56  681,815 
09/19/2022 62.54  63.99  62.07  63.80  915,977 
09/16/2022 63.63  63.92  61.69  62.56  2,127,822 
09/15/2022 66.00  68.05  64.68  64.75  1,065,272 
09/14/2022 65.31  67.53  64.83  66.67  878,262 
09/13/2022 66.50  66.92  64.44  65.05  892,976 

About Apellis Pharmaceuticals Stock history

Apellis Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Apellis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Apellis Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Apellis Pharmaceuticals historical stock prices may prove useful in developing a viable investing in Apellis Pharmaceuticals
Last ReportedProjected for 2022
Weighted Average Shares84.4 M91.1 M
Weighted Average Shares Diluted84.4 M91.1 M
Issuance Purchase of Equity Shares398 M323.9 M

Apellis Pharmaceuticals Stock Technical Analysis

Apellis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Apellis Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Apellis Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Apellis Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Apellis stock's direction in advance. Along with the technical and fundamental analysis of Apellis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Apellis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please continue to Trending Equities. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for analysis

When running Apellis Pharmaceuticals price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Apellis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apellis Pharmaceuticals. If investors know Apellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apellis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.3 B
Quarterly Revenue Growth YOY
2.904
Return On Assets
(0.46) 
Return On Equity
(5.07) 
The market value of Apellis Pharmaceuticals is measured differently than its book value, which is the value of Apellis that is recorded on the company's balance sheet. Investors also form their own opinion of Apellis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Apellis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apellis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Apellis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apellis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Apellis Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apellis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.